Section Arrow
Quote
KMDA.NASDAQ
- Kamada Ltd
Quotes are at least 15-min delayed:2026/01/16 07:38 EST
Pre Market
Last
 --
-- (--)
Bid
8.05
Ask
8.5
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 8.22
+0.26 (+3.27%)
Day High 
8.4 
Prev. Close
7.96 
1-M High
8.2 
Volume 
111.55K 
Bid
8.05
Ask
8.5
Day Low
7.96 
Open
8 
1-M Low
6.92 
Market Cap 
459.15M 
Currency 美元 
P/E 22.74 
%Yield 2.43 
10-SMA 7.65 
20-SMA 7.38 
50-SMA 7.1 
52-W High 9.155 
52-W Low 5.54 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.35/1.97
Enterprise Value
468.58M
Balance Sheet
Book Value Per Share
4.60
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
160.95M
Operating Revenue Per Share
2.53
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SXTCChina SXT Pharmaceuticals Inc.0.1061+0.0098+10.18%-- 
Pre Market 0.0992 -0.0069 -6.50%
PRFXPainReform Ltd0.8191-0.0079-0.96%0.03PE
Pre Market 0.8862 +0.0671 +8.19%
IXHLIncannex Healthcare0.382-0.0067-1.72%-- 
Pre Market 0.388 +0.006 +1.57%
CGCCanopy Growth Corp1.22------ 
Pre Market 1.215 -0.005 -0.41%
HIMSHims & Hers Health31.23-0.09-0.29%58.77PE
Pre Market 31.4 +0.17 +0.54%
Industry overview quotes are at least 15 minutes delayed
Business Description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.